FDA Approved: ERIBULIN MESYLATE — Original Application (HIKMA PHARMACEUTICALS USA INC.)

View source ↗

Summary

FDA approved a generic version of eribulin mesylate (ERIBULIN MESYLATE) from Hikma Pharmaceuticals USA Inc. as an Original Application (ANDA 218281).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

ORIG AP for ERIBULIN MESYLATE (ERIBULIN MESYLATE)